CAC
KNTE

Cowen and Company’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Cowen and Company’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,000
Closed -$66.5K – 734
2024
Q1 		$66.5K Buy
+25,000
New +$66.5K ﹤0.01% 295